NCT01077791

Brief Summary

Theory of mind (ability to infer others' intention, emotion, etc) is known to be altered in patients with schizophrenia and its deficit to be correlated with their decreased social proficiency. We designed a novel cognitive therapy, that makes use of videos, aimed at learning a better use of contextual information to infer others' intentions. The aim of this study is to demonstrate, in schizophrenic patients, a quantitative improvement of their ability to infer intention of others induced by this novel training program. A secondary aim is to measure the cerebral correlates (MEG, PeV) of this social cognitive function and of its anticipated improvement.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for phase_2 schizophrenia

Timeline
Completed

Started Jul 2008

Typical duration for phase_2 schizophrenia

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2008

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

February 26, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 1, 2010

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2010

Completed
Last Updated

September 28, 2021

Status Verified

October 1, 2010

Enrollment Period

2.2 years

First QC Date

February 26, 2010

Last Update Submit

September 27, 2021

Conditions

Keywords

Schizophreniasocial cognitiontheory of mindcognitive therapytherapeutic trialmagnetoencephalography (MEG)

Outcome Measures

Primary Outcomes (1)

  • To demonstrate a measurable improvement of Theory of Mind based ability in schizophrenic patients induced by a novel cognitive therapy, as quantified by improvement of V-SIR scores (V-LIS scores in French literature).

    6 MONTHS

Secondary Outcomes (2)

  • To measure the extension of improvement to other cognitive functions - specific or non specific - and/or to every day life aptitudes

    6 MONTHS

  • To evaluate correlations with functional measurements (e.g., magneto-encephalography, cognitive evoked potentials) [transversal study; longitudinal study].

    6 MONTHS

Study Arms (2)

original cognitive therapy

EXPERIMENTAL
Behavioral: original cognitive therapy

no intervention

NO INTERVENTION

Interventions

12 weekly sequences of an original cognitive therapy based on videos involving the learning of a better use of contextual information to infer others' intention. Group of 5 patients trained by 2 therapeutics. Comparison with a non-cognitive psychoeducational training (same organisational design).

original cognitive therapy

Eligibility Criteria

Age18 Years - 57 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Schizophrenia following DSM IV;
  • Age 18-57;
  • Stability of the clinical state;
  • Ability to learn;
  • Deficit in intention reading as measure with the V-SIR (V-LIS in French) test (score \>13);
  • informed consent to participate to the study.

You may not qualify if:

  • Any other organic or neuropsychiatric disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre hospitalier de Versailles. Service de Psychiatrie.

Le Chesnay, 78157, France

Location

MeSH Terms

Conditions

Schizophrenia

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Study Officials

  • Catherine Bourdet, MD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2010

First Posted

March 1, 2010

Study Start

July 1, 2008

Primary Completion

September 1, 2010

Study Completion

September 1, 2010

Last Updated

September 28, 2021

Record last verified: 2010-10

Locations